HK1085219A1 - Inhibitors of nucleoside phosphorylases and nucleosidases - Google Patents
Inhibitors of nucleoside phosphorylases and nucleosidasesInfo
- Publication number
- HK1085219A1 HK1085219A1 HK06105174A HK06105174A HK1085219A1 HK 1085219 A1 HK1085219 A1 HK 1085219A1 HK 06105174 A HK06105174 A HK 06105174A HK 06105174 A HK06105174 A HK 06105174A HK 1085219 A1 HK1085219 A1 HK 1085219A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhibitors
- compounds
- phosphorylases
- nucleosidases
- methylthioadenosine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Seal Device For Vehicle (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ52091902 | 2002-08-21 | ||
PCT/NZ2003/000186 WO2004018496A1 (fr) | 2002-08-21 | 2003-08-21 | Inhibiteurs des phosphorylases de nucleoside et des nucleosidases |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1085219A1 true HK1085219A1 (en) | 2006-08-18 |
Family
ID=31944950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06105174A HK1085219A1 (en) | 2002-08-21 | 2006-05-02 | Inhibitors of nucleoside phosphorylases and nucleosidases |
Country Status (18)
Country | Link |
---|---|
US (2) | US7553839B2 (fr) |
EP (1) | EP1539783B1 (fr) |
JP (1) | JP4682314B2 (fr) |
KR (1) | KR101081226B1 (fr) |
CN (1) | CN100379750C (fr) |
AT (1) | ATE505474T1 (fr) |
AU (1) | AU2003258911B2 (fr) |
BR (1) | BRPI0313664B8 (fr) |
CA (1) | CA2496698C (fr) |
CY (1) | CY1111700T1 (fr) |
DE (1) | DE60336734D1 (fr) |
DK (1) | DK1539783T3 (fr) |
ES (1) | ES2363766T3 (fr) |
HK (1) | HK1085219A1 (fr) |
PT (1) | PT1539783E (fr) |
RU (1) | RU2330042C2 (fr) |
SI (1) | SI1539783T1 (fr) |
WO (1) | WO2004018496A1 (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985848A (en) * | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
ATE425165T1 (de) | 1999-04-08 | 2009-03-15 | Ind Res Ltd | Verfahren zur zubereitung von inhibitoren des nukleosid-metabolismus |
SI1539783T1 (sl) | 2002-08-21 | 2011-08-31 | Einstein Coll Med | Inhibitorji nukleozidnih fosforilaz in nukleozidaz |
NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
MXPA06002001A (es) * | 2003-08-26 | 2006-06-20 | Teijin Pharma Ltd | Derivados pirrolopirimidinona. |
US7557113B2 (en) | 2003-08-26 | 2009-07-07 | Teijin Pharma Limited | Substituted pyrrolo[3,2-d]pyrimidine derivatives |
NZ533360A (en) * | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
JP2008508287A (ja) * | 2004-07-27 | 2008-03-21 | バイオクリスト・フアーマシユーテイカルズ・インコーポレイテツド | 5’−メチルチオアデノシンホスホリラーゼ及び5’メチルチオアデノシン/s−アデノシルホモシステインヌクレオシダーゼの阻害剤 |
NZ540160A (en) * | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
US8541567B2 (en) * | 2005-07-27 | 2013-09-24 | Albert Einstein College Of Medicine Of Yeshiva University | Transition state structure of 5′-methylthioadenosine/s-adenosylhomocysteine nucleosidases |
NZ544187A (en) * | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
US20090053221A1 (en) * | 2006-01-17 | 2009-02-26 | Cheung Nai-Kong V | Immune response enhancing glucan |
WO2007097643A1 (fr) * | 2006-02-22 | 2007-08-30 | Industrial Research Limited | Analogues de coformycine et leur utilisation pour le traitement d'infections de parasites protozoaires |
AU2006200809B2 (en) * | 2006-02-24 | 2013-11-07 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer |
WO2007097648A1 (fr) * | 2006-02-24 | 2007-08-30 | Industrial Research Limited | Méthodes de traitement de maladies en utilisant des inhibiteurs de nucléoside phosphorylases et de nucléosidases |
US8916571B2 (en) * | 2006-02-24 | 2014-12-23 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase |
CN101094080B (zh) * | 2006-06-22 | 2012-06-20 | 华为技术有限公司 | 一种即按即通系统中的计费方法 |
AU2007293774C1 (en) | 2006-09-07 | 2014-12-18 | Albert Einstein College Of Medicine, Inc. | Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
CA2662626C (fr) * | 2006-09-07 | 2016-07-26 | Industrial Research Limited | Inhibiteurs amines acycliques de la 5'-methylthioadenosine phosphorylase et nucleosidase |
KR20090101278A (ko) | 2006-12-22 | 2009-09-24 | 인더스트리얼 리서치 리미티드 | 누클레오시다제 및 포스포릴라제 억제제의 아제티딘 유사체 |
WO2009082247A1 (fr) * | 2007-12-21 | 2009-07-02 | Industrial Research Limited | Procédé de préparation d'immucillines à liaison méthylène |
UA103195C2 (uk) | 2008-08-11 | 2013-09-25 | Глаксосмитклайн Ллк | Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань |
WO2010033236A2 (fr) | 2008-09-22 | 2010-03-25 | Albert Einstein College Of Medicine Of Yeshiva University | Procédés et compositions pour le traitement d’infections bactériennes par l’inhibition de la détection du quorum |
EA020931B1 (ru) * | 2009-03-24 | 2015-02-27 | Байокрист Фармасьютикалз, Инк. | ПОЛЕЗНЫЕ ФАРМАЦЕВТИЧЕСКИЕ СОЛИ 7-[(3R,4R)-3-ГИДРОКСИ-4-ГИДРОКСИМЕТИЛПИРРОЛИДИН-1-ИЛМЕТИЛ]-3,5-ДИГИДРОПИРРОЛО[3,2-d]ПИРИМИДИН-4-ОНА |
US9493465B2 (en) | 2009-07-17 | 2016-11-15 | Victoria Link Limited | 3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucleosidase |
WO2012074912A1 (fr) * | 2010-11-29 | 2012-06-07 | Albert Einstein College Of Medicine Of Yeshiva University | Procédés, essais et composés pour le traitement d'infections bactériennes par l'inhibition de la méthylthioinosine phosphorylase |
WO2012122532A2 (fr) * | 2011-03-09 | 2012-09-13 | Biocryst Pharmaceuticals, Inc. | Compositions et méthodes de traitement de l'hyperuricémie |
KR101916928B1 (ko) | 2011-07-22 | 2018-11-08 | 글락소스미스클라인 엘엘씨 | 조성물 |
JP6063571B2 (ja) * | 2012-08-07 | 2017-01-18 | アルバート アインシュタイン カレッジ オブ メディシン,インコーポレイティド | ヘリコバクター・ピロリ感染の治療 |
TWI625331B (zh) | 2012-08-24 | 2018-06-01 | 葛蘭素史密斯克藍有限責任公司 | 可作為干擾素誘導物之化合物及其組合物及用途 |
US9994574B2 (en) | 2012-11-12 | 2018-06-12 | Victoria Link Limited | Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-d]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(MTDIA) |
CA2890198A1 (fr) | 2012-11-20 | 2014-05-30 | Diane Mary Coe | Nouveaux composes |
WO2014081644A1 (fr) | 2012-11-20 | 2014-05-30 | Glaxosmithkline Llc | Nouveaux composés |
WO2014081645A1 (fr) | 2012-11-20 | 2014-05-30 | Glaxosmithkline Llc | Nouveaux composés |
US9616129B2 (en) | 2013-06-22 | 2017-04-11 | Nitor Therapeutics | Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency |
SG11201606595RA (en) | 2014-02-12 | 2016-09-29 | Einstein Coll Med | Treatment of h. pylori infections using mtan inhibitors |
EP2913333A1 (fr) * | 2014-02-27 | 2015-09-02 | Laboratoire Biodim | Composés de 3H-thieno[3,4]pyrimidin-4-one et pyrrolopyrimidone comme agents antibactériens Gram-Positif. |
CN108794628A (zh) * | 2018-05-28 | 2018-11-13 | 广东工业大学 | 一种抗幽门螺杆菌的卵黄抗体制备方法及应用 |
GB202110403D0 (en) | 2021-07-20 | 2021-09-01 | Laevoroc Immunology | Ulodesine Salt |
GB202218782D0 (en) | 2022-12-13 | 2023-01-25 | Mehrling Thomas | Purine nucleoside phosphorylase inhibitor for metabolic syndrome |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991006548A1 (fr) * | 1989-10-31 | 1991-05-16 | Biocryst, Inc. | Inhibiteurs de phosphorylase de nucleoside de purine |
JPH07242668A (ja) * | 1994-03-08 | 1995-09-19 | Nippon Kayaku Co Ltd | 新規なアゼチジン誘導体 |
HUT77436A (hu) * | 1994-10-05 | 1998-04-28 | Darwin Discovery Limited | Purin- és guaninszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására |
JP3088757B2 (ja) | 1995-03-29 | 2000-09-18 | 大鵬薬品工業株式会社 | ウラシル誘導体並びにそれを含有する抗腫瘍効果増強剤及び抗腫瘍剤 |
AU1739097A (en) * | 1996-02-23 | 1997-09-10 | Albert Einstein College Of Medicine Of Yeshiva University | Enzyme detection/assay method and substrates |
US5985848A (en) | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
ATE425165T1 (de) * | 1999-04-08 | 2009-03-15 | Ind Res Ltd | Verfahren zur zubereitung von inhibitoren des nukleosid-metabolismus |
US6448799B1 (en) * | 1999-09-30 | 2002-09-10 | Hitachi Electronics Engineering Co., Ltd. | Timing adjustment method and apparatus for semiconductor IC tester |
JP4110347B2 (ja) | 1999-11-05 | 2008-07-02 | 大鵬薬品工業株式会社 | 抗hiv剤 |
US7109331B2 (en) * | 2000-08-29 | 2006-09-19 | Industrial Research Limited | 5H-pyrrolo[3,2-d]pyrimidine nucleoside metabolism inhibitors |
US6458799B1 (en) | 2000-08-31 | 2002-10-01 | Biocryst Pharmaceuticals, Inc. | Deazaguanine analog, preparation thereof and use thereof |
US7098334B2 (en) * | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
SI1539783T1 (sl) | 2002-08-21 | 2011-08-31 | Einstein Coll Med | Inhibitorji nukleozidnih fosforilaz in nukleozidaz |
NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
NZ533360A (en) * | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
JP2008508287A (ja) | 2004-07-27 | 2008-03-21 | バイオクリスト・フアーマシユーテイカルズ・インコーポレイテツド | 5’−メチルチオアデノシンホスホリラーゼ及び5’メチルチオアデノシン/s−アデノシルホモシステインヌクレオシダーゼの阻害剤 |
NZ540160A (en) | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
US8541567B2 (en) | 2005-07-27 | 2013-09-24 | Albert Einstein College Of Medicine Of Yeshiva University | Transition state structure of 5′-methylthioadenosine/s-adenosylhomocysteine nucleosidases |
NZ544187A (en) * | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
WO2007097648A1 (fr) | 2006-02-24 | 2007-08-30 | Industrial Research Limited | Méthodes de traitement de maladies en utilisant des inhibiteurs de nucléoside phosphorylases et de nucléosidases |
US8916571B2 (en) * | 2006-02-24 | 2014-12-23 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase |
CA2662626C (fr) * | 2006-09-07 | 2016-07-26 | Industrial Research Limited | Inhibiteurs amines acycliques de la 5'-methylthioadenosine phosphorylase et nucleosidase |
AU2007293774C1 (en) | 2006-09-07 | 2014-12-18 | Albert Einstein College Of Medicine, Inc. | Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
CA2663562A1 (fr) * | 2006-09-26 | 2008-04-03 | Vern L. Schramm | Structure d'etat de transition d'une 5'-methylthioadenosine phosphorylase humaine |
KR20090101278A (ko) * | 2006-12-22 | 2009-09-24 | 인더스트리얼 리서치 리미티드 | 누클레오시다제 및 포스포릴라제 억제제의 아제티딘 유사체 |
WO2009082247A1 (fr) | 2007-12-21 | 2009-07-02 | Industrial Research Limited | Procédé de préparation d'immucillines à liaison méthylène |
WO2010033236A2 (fr) | 2008-09-22 | 2010-03-25 | Albert Einstein College Of Medicine Of Yeshiva University | Procédés et compositions pour le traitement d’infections bactériennes par l’inhibition de la détection du quorum |
US9493465B2 (en) | 2009-07-17 | 2016-11-15 | Victoria Link Limited | 3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucleosidase |
-
2003
- 2003-08-21 SI SI200332011T patent/SI1539783T1/sl unknown
- 2003-08-21 CA CA2496698A patent/CA2496698C/fr not_active Expired - Lifetime
- 2003-08-21 DE DE60336734T patent/DE60336734D1/de not_active Expired - Lifetime
- 2003-08-21 KR KR1020057002959A patent/KR101081226B1/ko active IP Right Grant
- 2003-08-21 PT PT03792904T patent/PT1539783E/pt unknown
- 2003-08-21 RU RU2005107714/04A patent/RU2330042C2/ru active
- 2003-08-21 CN CNB038243547A patent/CN100379750C/zh not_active Expired - Lifetime
- 2003-08-21 AU AU2003258911A patent/AU2003258911B2/en not_active Expired
- 2003-08-21 US US10/524,995 patent/US7553839B2/en not_active Expired - Lifetime
- 2003-08-21 WO PCT/NZ2003/000186 patent/WO2004018496A1/fr active Application Filing
- 2003-08-21 AT AT03792904T patent/ATE505474T1/de active
- 2003-08-21 ES ES03792904T patent/ES2363766T3/es not_active Expired - Lifetime
- 2003-08-21 DK DK03792904.9T patent/DK1539783T3/da active
- 2003-08-21 BR BRPI0313664A patent/BRPI0313664B8/pt active IP Right Grant
- 2003-08-21 JP JP2004530687A patent/JP4682314B2/ja not_active Expired - Lifetime
- 2003-08-21 EP EP03792904A patent/EP1539783B1/fr not_active Expired - Lifetime
-
2006
- 2006-05-02 HK HK06105174A patent/HK1085219A1/xx not_active IP Right Cessation
-
2009
- 2009-06-03 US US12/455,537 patent/US8173662B2/en active Active
-
2011
- 2011-07-12 CY CY20111100673T patent/CY1111700T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2003258911B2 (en) | 2009-11-19 |
EP1539783A1 (fr) | 2005-06-15 |
KR20050093756A (ko) | 2005-09-23 |
RU2330042C2 (ru) | 2008-07-27 |
US20060160765A1 (en) | 2006-07-20 |
AU2003258911A1 (en) | 2004-03-11 |
DE60336734D1 (de) | 2011-05-26 |
CY1111700T1 (el) | 2015-10-07 |
JP2006501239A (ja) | 2006-01-12 |
CN100379750C (zh) | 2008-04-09 |
BR0313664A (pt) | 2005-07-12 |
CA2496698C (fr) | 2012-01-24 |
EP1539783B1 (fr) | 2011-04-13 |
RU2005107714A (ru) | 2006-01-20 |
PT1539783E (pt) | 2011-06-01 |
US7553839B2 (en) | 2009-06-30 |
US8173662B2 (en) | 2012-05-08 |
BRPI0313664B8 (pt) | 2021-05-25 |
CN1692120A (zh) | 2005-11-02 |
EP1539783A4 (fr) | 2010-05-19 |
US20090239885A1 (en) | 2009-09-24 |
ATE505474T1 (de) | 2011-04-15 |
SI1539783T1 (sl) | 2011-08-31 |
BRPI0313664B1 (pt) | 2021-03-23 |
WO2004018496A1 (fr) | 2004-03-04 |
JP4682314B2 (ja) | 2011-05-11 |
KR101081226B1 (ko) | 2011-11-07 |
ES2363766T3 (es) | 2011-08-16 |
DK1539783T3 (da) | 2011-06-20 |
CA2496698A1 (fr) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1085219A1 (en) | Inhibitors of nucleoside phosphorylases and nucleosidases | |
EP1881984A4 (fr) | Inhibiteurs de nucleoside phosphorylases et de nucleosidases | |
HK1131612A1 (en) | Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases | |
MXPA04003668A (es) | Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos. | |
MY132106A (en) | New pyridazin-3(2h)-one derivatives | |
ATE245648T1 (de) | 1h-pyrazolo(3,4-d)pyrimidine-4,6-dione als inhibitoren für die vermehrung von t-zellen | |
HUP0004211A2 (hu) | PDE-5 inhibitorok alkalmazása tüdõ magas vérnyomás kezelésére szolgáló gyógyszerkészítmények elõállítására | |
EP1624874A4 (fr) | Derives d'acide 3-amino-4-phenylbutanoique en tant qu'inhibiteurs de dipeptidyl peptidase dans le cadre du traitement ou de la prevention du diabete | |
IL169897A0 (en) | Sustituted heterocycles | |
PL376822A1 (pl) | Pochodne fenyloalaniny jako inhibitory dipeptydylopeptydazy do leczenia lub zapobiegania cukrzycy | |
TW200510343A (en) | Substituted dihydroquinazolines | |
PL367682A1 (en) | Dolastatin 10 derivatives | |
MX2009005011A (es) | Imidazopirazinas como inhibidores de proteina quinasa. | |
PL1789398T3 (pl) | Pochodne 2-amino-chinazoliny użyteczne jako inhibitory ß-sekretazy (BACE) | |
TW200612919A (en) | Lonidamine analogues and their use in male contraception and cancer treatment | |
HK1075450A1 (en) | heterocyclic compunds, process for their preparation and pharmaceutical compositions containing thenm and thier use in medicine | |
RS20050858A (en) | Composition comprising a pde4 inhibitor and a pde5 inhibitor | |
MY133995A (en) | 6-phenylpyrrolopyrimidinedione derivatives | |
HRP20050184B1 (hr) | Uporaba alkilfosfoholina u kombinaciji s protutumorskim lijekovima | |
WO2003017939A3 (fr) | Composes de piperazinone utilises comme agents antitumoraux et anticancereux et procedes de traitement | |
NO20053903L (no) | Nukleotidlipidesterderivater. | |
AU2003215680A1 (en) | New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives | |
TW200504051A (en) | Novel acridine derivatives and their use as medicaments | |
HUP0301915A2 (hu) | Sildenafil és egyéb PDE5 inhibitor hatású vegyületek alkalmazása korai magömlés kezelésére szolgáló gyógyszerkészítmény elżállítására | |
TW200500338A (en) | Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20230820 |